In addition, with the AUROC as 0.89 and 0.74, the serum GP73 exhibited excellent performance in identifying severe (G = 3) and moderate (G ≥ 2) inflammatory activity in MASH patients. This evidence concerns the gene GOLM1 and metabolic dysfunction-associated steatohepatitis.